We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Blackrock North American Income Trust Plc | LSE:BRNA | London | Ordinary Share | GB00B7W0XJ61 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 183.50 | 181.00 | 183.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBRNA BLACKROCK NORTH AMERICAN INCOME TRUST plc (LEI: 549300WWOCXSC241W468) All information is at 31 March 2017 and unaudited. Performance at month end with net income reinvested One Three Six One Three Since Month Months Months Year Years Launch* Net asset value -1.0% 1.9% 16.0% 36.7% 68.5% 101.8% Share price -2.6% -5.2% 11.2% 36.8% 64.4% 85.6% Russell 1000 Value Index -1.5% 2.0% 14.4% 37.0% 71.1% 128.0% Source: BlackRock *Launched on 24 October 2012. At month end Net asset value - capital only: 170.41p Net asset value - cum income: 171.33p Share price: 159.50p Discount to cum income NAV: 6.9% Net yield*: 3.0% Total assets including current year revenue: GBP118.1m Gearing: Nil Options overwrite: 16.67% Ordinary shares in issue**: 68,949,044 Ongoing charges***: 1.04% *Based on dividends of 1.20p per share declared on 21 February 2017, 3 November 2016, 3 August 2016 and 4 May 2016. ** Excluding 31,412,261 ordinary shares held in treasury. *** Ongoing charges represent the management fee and all other operating expenses excluding interest as a % of average shareholders' funds for the year ended 31 October 2016. Benchmark Sector Analysis Total Assets (%) Financials 27.0 Health Care 14.3 Industrials 10.8 Energy 10.6 Information Technology 9.6 Consumer Staples 6.5 Consumer Discretionary 5.4 Utilities 5.0 Materials 3.6 Telecommunication Services 2.1 Net current assets 5.1 ----- 100.0 ===== Country Analysis Total Assets (%) USA 84.5 United Kingdom 2.8 Canada 2.2 France 2.2 Netherlands 2.1 Ireland 0.7 China 0.4 Net current assets 5.1 ----- 100.0 ===== Ten Largest Investments Company Country of Risk Total Assets (%) JP Morgan Chase USA 4.4 Bank of America USA 4.2 Pfizer USA 3.7 Citigroup USA 3.2 Wells Fargo USA 2.9 Dow Chemical USA 2.7 General Electric USA 2.5 Oracle USA 2.5 Microsoft USA 2.4 Anthem USA 2.2 Bob Shearer and Tony DeSpirito, representing the Investment Manager, noted: Performance For the month of March, the Company's NAV decreased by 1.0% while the share price fell by 2.6% (all in sterling). The Company's benchmark, the Russell 1000 Value Index, returned -1.5% for the period. The largest contributor to relative performance during the month was stock selection in the information technology sector. Notably, selection decisions in the software and technology hardware, storage & peripherals industries proved to be beneficial. Stock selection in health care also added to relative returns, led by portfolio holdings in the pharmaceuticals and health care providers & services industries. Lastly, stock selection in the industrials and materials sectors also added to relative returns during the month. The largest detractor from relative performance was stock selection in the financials sector. Notably, our overweight positions in Morgan Stanley and Bank of America Corporation proved to be costly. Other modest detractors included stock selection in the utilities, consumer staples and energy sectors during the period. Transactions/Options Transactions: Notable portfolio transactions during the month included exiting our positions in Intel Corporation, CMS Energy Corporation, Raytheon Company and Pioneer Natural Resources Company. Proceeds from these trades were used to initiate a position in Constellation Software Inc. and to increase our exposure to portfolio holdings PG&E Corporation, Taiwan Semiconductor Manufacturing Company Limited and The Dow Chemical Company. Options: As of 31 March 2017, the Company's options exposure was 16.67% and the delta of the options was 88.39%. Positioning As at the period end, the Company's largest overweight positions relative to the benchmark were in the health care, consumer discretionary, materials and industrials sectors. The Company was approximately equal-weight in the financials sector, and was underweight to the real estate, consumer staples, energy, telecommunication services, utilities and information technology sectors. 25 April 2017 Latest information is available by typing blackrock.co.uk/brna on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement. END
(END) Dow Jones Newswires
April 25, 2017 11:28 ET (15:28 GMT)
1 Year Blackrock North American... Chart |
1 Month Blackrock North American... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions